NovaBay Pharmaceuticals, Inc. (NBY)

NYSEAMERICAN: NBY · IEX Real-Time Price · USD
1.54
+0.05 (3.36%)
Mar 24, 2023, 3:40 PM EDT - Market closed
3.36%
Market Cap 2.89M
Revenue (ttm) 12.14M
Net Income (ttm) -8.95M
Shares Out 1.88M
EPS (ttm) -5.60
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 7,843
Open 1.45
Previous Close 1.49
Day's Range 1.45 - 1.54
52-Week Range 1.24 - 12.60
Beta 2.77
Analysts Buy
Price Target 15.30 (+893.51%)
Earnings Date Mar 30, 2023

About NBY

NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, SPF, hyperhidrosis, excessive hair, and acne unde... [Read more]

Industry Biotechnology
Sector Healthcare
IPO Date Oct 26, 2007
Employees 29
Stock Exchange NYSEAMERICAN
Ticker Symbol NBY
Full Company Profile

Financial Performance

In 2021, NBY's revenue was $8.42 million, a decrease of -15.23% compared to the previous year's $9.93 million. Losses were -$6.56 million, -40.58% less than in 2020.

Financial Statements

Analyst Forecast

According to 6 analysts, the average rating for NBY stock is "Buy." The 12-month stock price forecast is $15.3, which is an increase of 893.51% from the latest price.

Price Target
$15.3
(893.51% upside)
Analyst Consensus: Buy
Stock Forecasts

News

NovaBay Pharmaceuticals to Hold 2022 Fourth Quarter and Full Year Conference Call on March 30, 2023

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the three and 12 months ended December 31, 2022 after marke...

1 day ago - Business Wire

Eyeganics Organic Tears, the Only USDA-Certified Organic Lubricant Eye Drop, Now Available through NovaBay Pharmaceuticals' Avenova.com and Physician-Dispensed Channel

EMERYVILLE, Calif. & KIRKWOOD, Mo.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces a partnership with Eyeganics to sell OTC Organic Tears (0.2% organic glycerin) on Ave...

1 week ago - Business Wire

NovaBay Pharmaceuticals Launches Avenova® Eye Health Support, a New Antioxidant-Rich Oral Supplement to Comfort Dry Eyes and Promote Overall Eye Health

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces the launch of OTC Avenova Eye Health Support oral supplement featuring a combination of MaquiBright®,...

2 weeks ago - Business Wire

NovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin to Discuss DERMAdoctor's Eczema Treatment on Two QVC® Shows on February 7

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that Chief Product Officer Audrey Kunin, MD will be a live on-air guest on two QVC network shows on...

1 month ago - Business Wire

NovaBay Pharmaceuticals to Present at the Virtual Sequire Biotechnology Conference on February 2, 2023

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that Justin Hall, CEO, will present a company overview at the virtual Sequire Biotechnology Confere...

1 month ago - Business Wire

PhaseOne Health and NovaBay Pharmaceuticals to Expand Commercial and Collaborative Strategies for the Wound Care Market

NASHVILLE, Tenn. & EMERYVILLE, Calif.--(BUSINESS WIRE)--PhaseOne Health announces the expansion of its commercial program for PhaseOne Skin and Wound Care Cleanser through collaborative partnerships...

2 months ago - Business Wire

NovaBay Pharmaceuticals Announces the Launch of DERMAdoctor's TikTok Store in China and Expands Online Marketing in the U.S. and China

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces the expansion of its lifestyle promotional video campaigns on TikTok and its Chinese counterpart Do...

4 months ago - Business Wire

NovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin Returns to the QVC® Network With DERMAdoctor's Eczema Balm

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a company developing and commercializing high-quality eyecare, skincare and wound care products, announces t...

4 months ago - Business Wire

NovaBay Pharmaceuticals Reports Third Quarter 2022 Financial Results

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) reports financial results for the three and nine months ended September 30, 2022 and provides a business upda...

4 months ago - Business Wire

NovaBay Pharmaceuticals Announces 1-for-35 Reverse Stock Split

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (the “Company”) (NYSE American: NBY) announces that today, following approval from the Company's stockholders obtained at the Comp...

4 months ago - Business Wire

NovaBay Pharmaceuticals to Present at the LD Micro Main Event XV

EMERYVILLE, Calif.

5 months ago - Business Wire

NovaBay Pharmaceuticals' Avenova® and DERMAdoctor® Products to be Featured During the October 11-12 Amazon Prime Early Access Sale

EMERYVILLE, Calif.--(BUSINESS WIRE)---- $NBY #Avenova--NovaBay Pharmaceuticals' Avenova and DERMAdoctor products featured during Amazon Early Access Prime event.

5 months ago - Business Wire

NovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Low Share Price

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that on October 3, 2022 it received a notice from the NYSE American LLC that the Company's common sto...

6 months ago - Business Wire

NovaBay Pharmaceuticals to Present at the Ladenburg Thalmann 2022 Healthcare Conference

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a pharmaceutical company developing and commercializing high-quality, scientifically formulated eyecare and sk...

6 months ago - Business Wire

NovaBay Pharmaceuticals CEO Issues Letter to Stockholders

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that Chief Executive Officer Justin Hall has issued the following Letter to Stockholders: To My Fello...

6 months ago - Business Wire

NovaBay Pharmaceuticals to Present at the Virtual Life Sciences Investor Forum

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a pharmaceutical company developing and commercializing high-quality, scientifically formulated eyecare and sk...

6 months ago - Business Wire

NovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin to Showcase DERMAdoctor's Eczema Balm on Return QVC® Appearance

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a company developing and commercializing high-quality, scientifically formulated eyecare and skincare products...

6 months ago - Business Wire

NovaBay Pharmaceuticals Enters Into Agreements For a Private Placement and Warrant Reprice Transactions To Raise Up to $5.3 Million

EMERYVILLE, Calif.--(BUSINESS WIRE)---- $NBY #Avenova--NovaBay Pharmaceuticals Enters Into Agreements For a Private Placement and Warrant Reprice Transactions To Raise Up to $5.3 Million

7 months ago - Business Wire

NovaBay Pharmaceuticals Reports Second Quarter 2022 Financial Results

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) reports financial results for the three and six months ended June 30, 2022 and provides a business update. Fina...

8 months ago - Business Wire

NovaBay Pharmaceuticals to Hold Second Quarter 2022 Conference Call on August 11

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the three and six months ended June 30, 2022 after market c...

8 months ago - Business Wire

NovaBay Pharmaceuticals Targets New Market with Antimicrobial Avenova® Lid and Lash Spray for Lash Extensions

EMERYVILLE, Calif.--(BUSINESS WIRE)---- $NBY #Avenova--NovaBay Pharmaceuticals targets the lash extension market with antimicrobial Avenova lid and lash spray.

8 months ago - Business Wire

NovaBay Pharmaceuticals' DERMAdoctor Products Now Available at Target.com and Urbanoutfitters.com

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a pharmaceutical company developing and commercializing high-quality, scientifically formulated eyecare and sk...

8 months ago - Business Wire